Note: Ingredients listed on restricted chemical lists
EC/CAS
236-948-9/13560-89-9
Name of the chemical
1,6,7,8,9,14,15,16,17,17,18,18-Dodecachloropentacyclo[12.2.1.1*6,9*.0*2,13*.0*5,10*]octadeca-7,15-diene
Concentration
>=20- <30
General Information
Version
3.0
Revision date
2023-01-13
Product name
URALANE 5774 AUS
Emergency telephone
+32 35 75 1234, +33(0)145425959, +65 6336-601 1, +86 20 39377888, +86 532 83889090, 91 22 42 87 5333, +1 800-424-9300, 353 (01) 8092166
Icons in SDS
Company Information
company name
Huntsman Advanced Materials (Europe) BVBA
e-mail address of the competent person responsible for the Safety Data Sheet
ctc-ems@boeingdistribution.com, Global_Product_EHS_AdMat@huntsman.com, ctcems@boeingdistribution.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H315, H317, H319, H334, H351, H373
Hazard statements
Code
Statements
H315
Causes skin irritation
Section 2
SECTION 2: Hazards identification
Regulation (EC) No. 1272/2008 Classification of the substance or mixture
Signal word
Danger
Hazard statements
H315 Causes skin irritation. H317 May cause an allergic skin reaction. H319 Causes serious eye irritation. H334 May cause allergy or asthma symptoms or breathing difficulties if inhaled. H351 Suspected of causing cancer. H373 May cause damage to organs through prolonged or repeated exposure.
Prevention
jPrecautionary statements P201 Obtain special instructions before use. P260 Do not breathe mist or vapours. P264 Wash skin thoroughly after handling. P280 Wear protective gloves/ protective clothing/ eye protection/ face protection/ hearing protection.
Response
P304 +P340 IF INHALED: Remove person to fresh air and keep comfortable for breathing. P342+P311 If experiencing respiratory symptoms: Calla POISON CENTER’ doctor.
Hazardous Ingredients
2-Oxepanone, polymer with 1,1'-methylenebis[4-isocyanatocyclohexane] and 2,2'- oxybis[ethanol]
Additional information
"As from 24 August 2023 adequate training is required before industrial or professional use." [|For204 Contains isocyanates. May produce an allergic reaction. 2.9 Other hazards This substance/mixture contains components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB).
ECOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher
TOXICOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher
2.1 Classification of the substance or mixture
Classification (REGULATION (EC) No 1272/2008) Skin irritation, Category 2 H315: Causes skin irritation. Eye irritation, Category 2 H319: Causes serious eye irritation. Respiratory sensitisation, Category 1 H334: May cause allergy or asthma symptoms or breathing difficulties if inhaled. Skin sensitisation, Category 1 H317: May cause an allergic skin reaction. Carcinogenicity, Category 2 H351: Suspected of causing cancer. Specific target organ toxicity - repeated H373: May cause damage to organs through exposure, Category 2 prolonged or repeated exposure.
